TCG Crossover Management, LLC — 13F Holdings

2026 Q3  ·  62 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, TCG Crossover Management, LLC maintained a portfolio of 62 distinct positions. The most significant new addition was KORSANA BIOSCIENCES INC, now representing 4.11% of the total fund value. They heavily accumulated shares in AURA BIOSCIENCES INC, increasing the position by 6.6%. The fund also reduced its exposure to ABIVAX SA AMERICAN DEPOSITARY by 39.0%.
Position History hover any row below to update
Loading…
TCG Crossover Management, LLC New York, NY Hedge Fund / Crossover Fund AUM $3,540M
PCA Score Concentration Risk
Risk ENB
Total Positions
62
Quarter
2026 Q3
Top Holding
ABVX (10.2%)
Top 10 Concentration
53.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 62

TCG Crossover Management, LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
ABVX
ABIVAX SA AMERI...
Healthcare 10.25% 19.24% #1
Prev: #1
6.0
—
-2,344,796 -39.0%
P
S
3,663,038 $362,714,023 2023 Q4 13F Filing 2026-09-30 2026-11-16
CGON
CG ONCOLOGY INC
Healthcare 7.35% 6.27% #2 1
Prev: #3
5.4
—
no change no change
P
S
3,670,206 $260,180,903 2024 Q1 13F Filing 2026-09-30 2026-11-16
AMLX
AMYLYX PHARMACE...
Healthcare 5.13% 2.70% #3 7
Prev: #10
4.1
—
no change no change
P
S
6,243,812 $181,694,929 2024 Q3 13F Filing 2026-09-30 2026-11-16
SYRE
SPYRE THERAPEUT...
Healthcare 4.78% 4.06% #4 2
Prev: #6
3.4
—
no change no change
P
S
1,900,582 $169,208,815 2025 Q3 13F Filing 2026-09-30 2026-11-16
TNGX
TANGO THERAPEUT...
Healthcare 4.77% 6.82% #5 3
Prev: #2
2.4
—
-2,308,158 -25.4%
P
S
6,773,043 $168,987,423 2022 Q1 13F Filing 2026-09-30 2026-11-16
ZLAB
ZAI LAB LTD-ADR
Healthcare 4.64% 2.80% #6 3
Prev: #9
2.4
—
91,454 1.5%
P
S
6,229,081 $164,073,994 2021 Q4 13F Filing 2026-09-30 2026-11-16
IMVT
IMMUNOVANT INC
Healthcare 4.25% 4.13% #7 2
Prev: #5
2.7
—
no change no change
P
S
4,457,988 $150,590,835 2022 Q4 13F Filing 2026-09-30 2026-11-16
DNTH
DIANTHUS THERAP...
Healthcare 4.17% 3.93% #8 1
Prev: #7
2.7
—
no change no change
P
S
1,676,624 $147,626,743 2024 Q4 13F Filing 2026-09-30 2026-11-16
KRSA
KORSANA BIOSCIE...
Healthcare 4.11% — #9
Prev: #—
5.1
—
4,549,587 —
NEW
4,549,587 $145,586,784 2026 Q3 13F Filing 2026-09-30 2026-11-16
KOD
KODIAK SCIENCES...
Healthcare 3.87% 1.35% #10 12
Prev: #22
2.5
—
no change no change
P
S
1,445,538 $137,037,002 2023 Q4 13F Filing 2026-09-30 2026-11-16
VOR
VOR BIOPHARMA I...
Healthcare 3.06% 2.51% #11 2
Prev: #13
2.2
—
no change no change
P
S
5,673,078 $108,242,328 2026 Q1 13F Filing 2026-09-30 2026-11-16
TRAX
FIRST TRACKS BI...
Healthcare 2.90% 1.40% #12 9
Prev: #21
2.2
—
no change no change
P
S
2,895,304 $102,609,574 2026 Q2 13F Filing 2026-09-30 2026-11-16
MIRM
MIRUM PHARMACEU...
Healthcare 2.70% 2.99% #13 5
Prev: #8
3.1
—
56,918 5.4%
P
S
1,118,967 $95,649,299 2025 Q4 13F Filing 2026-09-30 2026-11-16
BCRX
BIOCRYST PHARMA...
Healthcare 2.59% 2.65% #14 2
Prev: #12
2.0
—
no change no change
P
S
11,020,968 $91,804,663 2026 Q1 13F Filing 2026-09-30 2026-11-16
IRON
DISC MEDICINE I...
Healthcare 2.48% 2.36% #15 1
Prev: #16
2.0
—
no change no change
P
S
1,341,862 $87,838,287 2024 Q2 13F Filing 2026-09-30 2026-11-16
ADRX
ADARX PHARMACEU...
Healthcare 2.32% — #16
Prev: #—
4.4
—
4,116,452 —
NEW
4,116,452 $82,082,053 2026 Q3 13F Filing 2026-09-30 2026-11-16
COGT
COGENT BIOSCIEN...
Healthcare 2.26% 4.52% #17 13
Prev: #4
0.9
—
-2,354,433 -48.5%
P
S
2,500,003 $80,050,096 2021 Q4 13F Filing 2026-09-30 2026-11-16
TYRA
TYRA BIOSCIENCE...
Healthcare 2.15% 2.49% #18 4
Prev: #14
2.9
—
227,000 7.0%
P
S
3,475,980 $76,019,683 2021 Q4 13F Filing 2026-09-30 2026-11-16
DYN
DYNE THERAPEUTI...
Healthcare 2.10% 2.46% #19 4
Prev: #15
1.8
—
no change no change
P
S
4,615,144 $74,349,970 2023 Q1 13F Filing 2026-09-30 2026-11-16
RLAY
RELAY THERAPEUT...
Healthcare 1.93% 1.92% #20 3
Prev: #17
1.3
—
-489,827 -11.5%
P
S
3,783,529 $68,292,698 2025 Q3 13F Filing 2026-09-30 2026-11-16
AURA
AURA BIOSCIENCE...
Healthcare 1.80% 1.63% #21 2
Prev: #19
2.7
—
632,024 6.6%
P
S
10,165,357 $63,838,442 2026 Q2 13F Filing 2026-09-30 2026-11-16
SVRA
SAVARA INC
Healthcare 1.80% 1.83% #22 4
Prev: #18
1.7
—
no change no change
P
S
12,362,205 $63,788,978 2023 Q3 13F Filing 2026-09-30 2026-11-16
XNCR
XENCOR INC
Healthcare 1.45% 0.95% #23 4
Prev: #27
1.1
—
-396,200 -16.2%
P
S
2,055,938 $51,295,653 2024 Q3 13F Filing 2026-09-30 2026-11-16
AVTX
AVALO THERAPEUT...
Healthcare 1.31% 1.34% #24 1
Prev: #23
1.5
—
no change no change
P
S
3,017,120 $46,252,450 2024 Q3 13F Filing 2026-09-30 2026-11-16
GLUE
MONTE ROSA THER...
Healthcare 1.27% 2.69% #25 14
Prev: #11
1.0
—
-840,619 -18.2%
P
S
3,781,532 $45,113,677 2025 Q4 13F Filing 2026-09-30 2026-11-16
MBX
MBX BIOSCIENCES...
Healthcare 1.08% 0.86% #26 4
Prev: #30
1.4
—
no change no change
P
S
650,000 $38,103,000 2024 Q3 13F Filing 2026-09-30 2026-11-16
ENTX
ENTERA BIO LTD
Healthcare 1.01% — #27
Prev: #—
3.9
—
12,254,901 —
NEW
12,254,901 $35,661,762 2026 Q3 13F Filing 2026-09-30 2026-11-16
JANX
JANUX THERAPEUT...
Healthcare 0.87% 0.66% #28 7
Prev: #35
1.3
—
no change no change
P
S
1,789,617 $30,924,582 2025 Q4 13F Filing 2026-09-30 2026-11-16
TARS
TARSUS PHARMACE...
Healthcare 0.86% — #29
Prev: #—
3.8
—
388,164 —
NEW
388,164 $30,513,572 2023 Q3 13F Filing 2026-09-30 2026-11-16
IPSC
CENTURY THERAPE...
Healthcare 0.86% 1.04% #30 5
Prev: #25
1.3
—
no change no change
P
S
17,754,430 $30,360,075 2026 Q1 13F Filing 2026-09-30 2026-11-16
OBX
OBSIDIAN THERAP...
Healthcare 0.85% — #31
Prev: #—
3.8
—
2,196,138 —
NEW
2,196,138 $30,152,975 2026 Q3 13F Filing 2026-09-30 2026-11-16
PHVS
PHARVARIS BV
Healthcare 0.85% 0.84% #32 1
Prev: #31
0.8
—
-60,685 -6.0%
P
S
947,544 $30,056,096 2026 Q2 13F Filing 2026-09-30 2026-11-16
LBRX
LB PHARMACEUTIC...
Healthcare 0.83% 1.13% #33 9
Prev: #24
0.3
—
-682,260 -47.1%
P
S
765,050 $29,362,619 2025 Q3 13F Filing 2026-09-30 2026-11-16
EDIT
EDITAS MEDICINE...
Healthcare 0.81% 0.87% #34 5
Prev: #29
1.3
—
no change no change
P
S
11,111,111 $28,555,555 2026 Q2 13F Filing 2026-09-30 2026-11-16
TECX
TECTONIC THERAP...
Healthcare 0.79% 1.00% #35 9
Prev: #26
1.3
—
no change no change
P
S
1,204,891 $28,061,911 2026 Q1 13F Filing 2026-09-30 2026-11-16
IFRX
INFLARX N V
Healthcare 0.74% 0.78% #36 3
Prev: #33
1.3
—
no change no change
P
S
14,500,000 $26,100,000 2026 Q2 13F Filing 2026-09-30 2026-11-16
CATX
PERSPECTIVE THE...
Healthcare 0.61% 0.65% #37 1
Prev: #36
1.2
—
no change no change
P
S
7,915,567 $21,767,809 2026 Q1 13F Filing 2026-09-30 2026-11-16
AGMB
AGOMAB THERAPEU...
Healthcare 0.57% 0.64% #38 1
Prev: #37
0.7
—
-232,402 -11.3%
P
S
1,820,831 $20,211,224 2026 Q1 13F Filing 2026-09-30 2026-11-16
SLN
SILENCE THERAPE...
Healthcare 0.56% 0.80% #39 7
Prev: #32
0.2
—
-1,214,525 -40.0%
P
S
1,819,035 $19,882,053 2022 Q3 13F Filing 2026-09-30 2026-11-16
ALEC
ALECTOR INC
Healthcare 0.52% 0.48% #40
Prev: #40
1.2
—
no change no change
P
S
10,000,000 $18,500,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
BHVN
BIOHAVEN LTD
Healthcare 0.48% 0.64% #41 3
Prev: #38
0.2
—
-517,529 -29.1%
P
S
1,262,423 $16,853,347 2025 Q4 13F Filing 2026-09-30 2026-11-16
MNPR
MONOPAR THERAPE...
Healthcare 0.46% 0.45% #42
Prev: #42
0.7
—
-1,085 -0.5%
P
S
202,242 $16,112,620 2025 Q3 13F Filing 2026-09-30 2026-11-16
ADCT
ADC THERAPEUTIC...
Healthcare 0.39% 0.29% #43 1
Prev: #44
1.2
—
no change no change
P
S
11,390,175 $13,896,014 2025 Q3 13F Filing 2026-09-30 2026-11-16
TRDA
ENTRADA THERAPE...
Healthcare 0.19% 0.19% #44 2
Prev: #46
1.1
—
no change no change
P
S
1,060,230 $6,732,461 2021 Q4 13F Filing 2026-09-30 2026-11-16
CGEM
CULLINAN THERAP...
Healthcare 0.18% 0.18% #45 2
Prev: #47
1.1
—
no change no change
P
S
406,786 $6,244,165 2026 Q1 13F Filing 2026-09-30 2026-11-16
AGEN
AGENUS INC
Healthcare 0.17% — #46
Prev: #—
3.6
—
603,892 —
NEW
603,892 $5,996,648 2026 Q3 13F Filing 2026-09-30 2026-11-16
OCUL
OCULAR THERAPEU...
Healthcare 0.16% 0.39% #47 4
Prev: #43
0.1
—
-927,429 -56.3%
P
S
720,323 $5,524,877 2024 Q1 13F Filing 2026-09-30 2026-11-16
ARVN
ARVINAS INC
Healthcare 0.15% 0.14% #48
Prev: #48
1.1
—
no change no change
P
S
707,098 $5,469,403 2025 Q3 13F Filing 2026-09-30 2026-11-16
KRRO
KORRO BIO INC
Healthcare 0.12% 0.13% #49
Prev: #49
1.0
—
no change no change
P
S
416,301 $4,125,543 2025 Q3 13F Filing 2026-09-30 2026-11-16
N/A
RESEARCH ALLIAN...
Unknown 0.10% — #50
Prev: #—
3.5
—
300,000 —
NEW
300,000 $3,600,000 — 13F Filing 2026-09-30 2026-11-16
Showing 1-50 of 62 holdings

Unlock Full TCG Crossover Management, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →